Syneron’s Vela device gives you thinner legs
This article was originally published in The Gray Sheet
Firm gains 510(k) clearance and CE mark certification to market its Vela system for the temporary reduction of thigh circumference. Previously cleared for cellulite treatment, the device simultaneously applies light energy to the tissue at a controlled infrared wavelength, conducted RF energy, and "mechanical manipulations of the skin and fat layer," the company explains. The FDA clearance, announced Aug. 8, was based on a randomized study of 66 patients in the United States and Canada...
You may also be interested in...
In a statement submitted to the Senate Finance Committee, Natural Products Association CEO Dan Fabricant suggests two ways of improving compliance with new dietary ingredient notification requirements at negligible expense to the US FDA.
Public Company Edition: Legend Biotech raised $424m in its US public market debut. Also, Pfizer commits up to $500m for equity investments and Allogene capitalizes on ASCO with a $550m offering.
US FDA investigators are more likely to cite cell and gene therapy manufacturers for facilities and production deficiencies, agency says, while industry reports difficulties complying with drug GMP requirements that are not always applicable to cell and gene therapies.